Lv11
28 积分 2024-05-05 加入
Novel strategy for a bispecific antibody: induction of dual target internalization and degradation
                                            5小时前
                                            已完结
                                        
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
                                            5小时前
                                            已完结
                                        
Leucine Aminopeptidase LyLAP enables lysosomal degradation of membrane proteins
                                            7天前
                                            已完结
                                        
Harnessing DNA Nanotechnology for Nongenetic Manipulation and Functionalization of Cell Surface Receptor
                                            3个月前
                                            已完结
                                        
2023 Alzheimer's disease facts and figures
                                            4个月前
                                            已完结
                                        
Phototriggered LYTAC: Photoactive Bispecific Aptamer Chimera Enhances Targeted Degradation of Membrane Protein through Regulating Cell Autophagy
                                            4个月前
                                            已完结
                                        
Chemical Tailoring of Aptamer Glues with Significantly Enhanced Recognition Ability for Targeted Membrane Protein Degradation
                                            4个月前
                                            已完结
                                        
Conditionally Activatable Chimeras for Tumor-Specific Membrane Protein Degradation
                                            4个月前
                                            已完结
                                        
An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice
                                            4个月前
                                            已完结
                                        
Faricimab: First Approval
                                            5个月前
                                            已完结